Logo image of ALVGO.PA

VOGO SACA (ALVGO.PA) Stock Fundamental Analysis

EPA:ALVGO - Euronext Paris - Matif - FR0011532225 - Common Stock - Currency: EUR

2.65  0 (0%)

Fundamental Rating

2

Overall ALVGO gets a fundamental rating of 2 out of 10. We evaluated ALVGO against 103 industry peers in the Software industry. Both the profitability and financial health of ALVGO have multiple concerns. ALVGO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALVGO had negative earnings in the past year.
In the past year ALVGO has reported a negative cash flow from operations.
ALVGO had negative earnings in each of the past 5 years.
In the past 5 years ALVGO always reported negative operating cash flow.
ALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.50%, ALVGO is doing worse than 71.84% of the companies in the same industry.
ALVGO has a Return On Equity of -14.65%. This is in the lower half of the industry: ALVGO underperforms 68.93% of its industry peers.
Industry RankSector Rank
ROA -7.5%
ROE -14.65%
ROIC N/A
ROA(3y)-8.46%
ROA(5y)-9.78%
ROE(3y)-20.42%
ROE(5y)-23.22%
ROIC(3y)N/A
ROIC(5y)N/A
ALVGO.PA Yearly ROA, ROE, ROICALVGO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

With a Gross Margin value of 57.07%, ALVGO is not doing good in the industry: 63.11% of the companies in the same industry are doing better.
ALVGO's Gross Margin has improved in the last couple of years.
ALVGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.4%
GM growth 5YN/A
ALVGO.PA Yearly Profit, Operating, Gross MarginsALVGO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

ALVGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALVGO has more shares outstanding
ALVGO has more shares outstanding than it did 5 years ago.
ALVGO has a worse debt/assets ratio than last year.
ALVGO.PA Yearly Shares OutstandingALVGO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALVGO.PA Yearly Total Debt VS Total AssetsALVGO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of 0.96, we must say that ALVGO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.96, ALVGO is doing worse than 74.76% of the companies in the same industry.
ALVGO has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
ALVGO has a Debt to Equity ratio (0.43) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACC8.03%
ALVGO.PA Yearly LT Debt VS Equity VS FCFALVGO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

ALVGO has a Current Ratio of 1.85. This is a normal value and indicates that ALVGO is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.85, ALVGO is doing good in the industry, outperforming 73.79% of the companies in the same industry.
ALVGO has a Quick Ratio of 1.02. This is a normal value and indicates that ALVGO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALVGO (1.02) is worse than 63.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.02
ALVGO.PA Yearly Current Assets VS Current LiabilitesALVGO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

ALVGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.08%, which is quite impressive.
ALVGO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.25%.
ALVGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.80% yearly.
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.64%
Revenue 1Y (TTM)10.25%
Revenue growth 3Y7.48%
Revenue growth 5Y42.8%
Sales Q2Q%-3.4%

3.2 Future

Based on estimates for the next years, ALVGO will show a very strong growth in Earnings Per Share. The EPS will grow by 43.93% on average per year.
Based on estimates for the next years, ALVGO will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y42.5%
EPS Next 2Y33.23%
EPS Next 3Y43.93%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y4.45%
Revenue Next 3Y7.06%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVGO.PA Yearly Revenue VS EstimatesALVGO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALVGO.PA Yearly EPS VS EstimatesALVGO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALVGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALVGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALVGO.PA Price Earnings VS Forward Price EarningsALVGO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVGO.PA Per share dataALVGO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ALVGO's earnings are expected to grow with 43.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.23%
EPS Next 3Y43.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALVGO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VOGO SACA

EPA:ALVGO (8/8/2025, 7:00:00 PM)

2.65

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-23 2025-07-23
Earnings (Next)02-03 2026-02-03
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners28.99%
Ins Owner ChangeN/A
Market Cap16.24M
Analysts84
Price Target2.81 (6.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-26.67%
Revenue NY rev (3m)-26.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.53
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 8.35
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.73
BVpS2.01
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.5%
ROE -14.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.07%
FCFM N/A
ROA(3y)-8.46%
ROA(5y)-9.78%
ROE(3y)-20.42%
ROE(5y)-23.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.4%
GM growth 5YN/A
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 154.34%
Cap/Sales 20.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.02
Altman-Z 0.96
F-Score4
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)200.88%
Cap/Depr(5y)198.36%
Cap/Sales(3y)20.88%
Cap/Sales(5y)19.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.64%
EPS Next Y42.5%
EPS Next 2Y33.23%
EPS Next 3Y43.93%
EPS Next 5YN/A
Revenue 1Y (TTM)10.25%
Revenue growth 3Y7.48%
Revenue growth 5Y42.8%
Sales Q2Q%-3.4%
Revenue Next Year0%
Revenue Next 2Y4.45%
Revenue Next 3Y7.06%
Revenue Next 5YN/A
EBIT growth 1Y0.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.33%
EBIT Next 3Y42.96%
EBIT Next 5YN/A
FCF growth 1Y29.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.51%
OCF growth 3YN/A
OCF growth 5YN/A